THERMA BRIGHT INC (THRM.CA) Stock Overview
Canada - TSX-V:THRM - CA8834262070 - Common Stock
THRM.CA Key Statistics, Chart & Performance
The current stock price of THRM.CA is 0.075 CAD. In the past month the price decreased by -25%. In the past year, price decreased by -76.56%.
THRM.CA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| PRN.CA | PROFOUND MEDICAL CORP | N/A | 222.59M | ||
| MIR.CA | MEDMIRA INC | N/A | 64.46M | ||
| TLT.CA | THERALASE TECHNOLOGIES INC | N/A | 52.03M | ||
| CNVI.CA | CONAVI MEDICAL CORP | N/A | 45.28M | ||
| PINK.CA | PERIMETER MEDICAL IMAGING AI | N/A | 28.51M | ||
| ASG.CA | AURORA SPINE CORP | N/A | 22.39M | ||
| NSCI.CA | NANALYSIS SCIENTIFIC CORP | N/A | 20.67M | ||
| VPT.CA | VENTRIPOINT DIAGNOSTICS LTD | N/A | 18.45M | ||
| MDX.CA | MEDX HEALTH CORP | N/A | 18.11M | ||
| IDL.CA | IMAGING DYNAMICS CO LTD | N/A | 309.90K | ||
| VVTM.CA | VVT MED INC | N/A | 21.38M |
Related stock screener links
About THRM.CA
Company Profile
Therma Bright, Inc. engages in developing and marketing skin care medical device products. The company is headquartered in Toronto, Ontario. The company went IPO on 2001-07-11. The firm is developing, acquiring, manufacturing and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace focused on three key strategic areas: respiratory disease, vascular health and consumer medical devices. Its respiratory disease portfolio includes AI4LYF Digital Cough Technology and InStatin-novel inhaled treatment for asthma and COPD. Its vascular disease portfolio includes Inretio-ischemic stroke treatment and Venowave-Deep Vein Thrombosis Treatment Device (DVT). Its consumer health portfolio consists of AcuVid Covid-19 Rapid Antigen Saliva Test, Benepod-Contrast Therapy Device, TheroZAP-Thermal Therapy Device and InterceptCS-Cold Sore Prevention System. The firm holds trademarks for Therozap, InterceptCS and AcuVid.
Company Info
THERMA BRIGHT INC
345 Danforth Avenue
TORONTO ONTARIO M4M 3P1 CA
CEO: Rob Fia
Employees: 0
Phone: 18442746837
THERMA BRIGHT INC / THRM.CA FAQ
What does THRM do?
Therma Bright, Inc. engages in developing and marketing skin care medical device products. The company is headquartered in Toronto, Ontario. The company went IPO on 2001-07-11. The firm is developing, acquiring, manufacturing and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace focused on three key strategic areas: respiratory disease, vascular health and consumer medical devices. Its respiratory disease portfolio includes AI4LYF Digital Cough Technology and InStatin-novel inhaled treatment for asthma and COPD. Its vascular disease portfolio includes Inretio-ischemic stroke treatment and Venowave-Deep Vein Thrombosis Treatment Device (DVT). Its consumer health portfolio consists of AcuVid Covid-19 Rapid Antigen Saliva Test, Benepod-Contrast Therapy Device, TheroZAP-Thermal Therapy Device and InterceptCS-Cold Sore Prevention System. The firm holds trademarks for Therozap, InterceptCS and AcuVid.
Can you provide the latest stock price for THERMA BRIGHT INC?
The current stock price of THRM.CA is 0.075 CAD.
Does THERMA BRIGHT INC pay dividends?
THRM.CA does not pay a dividend.
How is the ChartMill rating for THERMA BRIGHT INC?
THRM.CA has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Should I buy THRM stock?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on THRM.CA.
Can you provide the number of employees for THERMA BRIGHT INC?
THERMA BRIGHT INC (THRM.CA) currently has 0 employees.
THRM.CA Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to THRM.CA. When comparing the yearly performance of all stocks, THRM.CA is a bad performer in the overall market: 96.29% of all stocks are doing better.
THRM.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to THRM.CA. THRM.CA has a bad profitability rating. Also its financial health evaluation is rather negative.
THRM.CA Financial Highlights
Over the last trailing twelve months THRM.CA reported a non-GAAP Earnings per Share(EPS) of -0.05. The EPS increased by 19.03% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -100.59% | ||
| ROE | -261.64% | ||
| Debt/Equity | 0.04 |